Roanna Ruiz Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

Roanna Ruiz

Stock Analyst at Leerink Partners

(3.7)
# 2456
Out of 5,506 analysts
79
Total ratings
Success rate
Average return

21 Stocks

Name Action PT Current % Upside Ratings Updated
XERS Xeris Biopharma Hold...
Maintains: Outperform
7 9
8.2 9.76% 7 Aug 19, 2025
AKBA Akebia Therapeutics
Initiates Coverage On: Outperform
7
2.83 147.35% 1 Apr 28, 2025
CRMD Cormedix
Initiates Coverage On: Outperform
18
11.34 58.73% 1 Mar 7, 2025
LXRX Lexicon Pharmaceutic...
Downgrades: Market Perform
1
1.41 -29.08% 1 Mar 4, 2025
VIR Vir Biotechnology
Maintains: Outperform
18 20
5.73 249.04% 4 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 27
10.31 161.88% 4 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 13
5.8 124.14% 3 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
5.26 166.16% 1 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
330
453.07 -27.16% 1 Feb 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
58
56.97 1.81% 1 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
25
88.15 -71.64% 1 Apr 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 2
n/a n/a 4 Apr 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Perform
49
10.33 374.35% 10 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 13
5.67 129.28% 7 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
8 6
2.9 106.9% 6 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
19
30.67 -38.05% 1 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
110 120
53.83 122.92% 3 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
75 50
10.07 396.52% 7 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
23 27
n/a n/a 7 Oct 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
60 40
18.84 112.31% 6 Oct 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
720 80
n/a n/a 3 Jul 14, 2022